Fremanezumab for preventing migraine

2nd September 2020 by Dr Louise Hudman

Fremanezumab for preventing migraine

This is a new guideline from NICE advising that we can use fremanezumab for preventing migraine in selected populations. It was published in June 2020.

It can be used if:

  • the migraine is chronic ie 15 or more headache days each month for at least 3 months, with at least 8 of those days having features of migraine AND
  • at least three preventative drugs have failed AND
  • it is provided according to the commercial agreements with the company.

It should be stopped if it does not reduce migraine frequency by 30% after 12 weeks of treatment.

Read for free

Sign up to access everything.

Free trial


Already a member? Login to view this content.


"LocumDeck is so good and so intuitive that I am lost for words and utterly filled with glee.

It can send an email confirming the sessions that are booked and creates and emails invoices direct to the practice for you. These contain links to your beautifully laid out ‘credentials’ page with all your relevant documents, and a model contract that is all ready for you to accept or edit.

It automatically produces and sends the locum form A, and will produce locum form B. It also acts as the calendar... And it all happens automatically. It is really less than a minute to invoice and do the pension forms, with everything calculated perfectly."

Dr Annette Steele

See the full list of features within our NASGP membership plans